In this work, the supercritical antisolvent (SAS) coprecipitation of zein with amoxicillin trihydrate (AMOXI) and ampicillin sodium salt (AMPI), two commonly used broad-spectrum antibiotics is proposed. In order to precipitate composite microspheres with controlled dimensions, the proper conditions, in terms of operating temperature and zein/antibiotic ratio, were identified. In the case of amoxicillin trihydrate, at 90 bar, 40 °C, 50 mg/mL and zein/AMOXI ratio equal to 20/1, spherical microparticles with mean diameter equal to 0.65±0.51 μm were successfully produced. In the case of ampicillin sodium salt, at 90 bar, 50 °C, 50 mg/mL and zein/AMPI ratio equal to 5/1, spherical microparticles with mean diameter equal to 9.0±5.7 μm were precipitated. Drug release analyses revealed that the release of the antibiotics was significantly delayed, confirming that zein/antibiotic coprecipitates obtained by SAS can be used for controlled-release formulations.

Production of zein/antibiotic microparticles by supercritical antisolvent coprecipitation

Franco, Paola;Reverchon, Ernesto;De Marco, Iolanda
2019-01-01

Abstract

In this work, the supercritical antisolvent (SAS) coprecipitation of zein with amoxicillin trihydrate (AMOXI) and ampicillin sodium salt (AMPI), two commonly used broad-spectrum antibiotics is proposed. In order to precipitate composite microspheres with controlled dimensions, the proper conditions, in terms of operating temperature and zein/antibiotic ratio, were identified. In the case of amoxicillin trihydrate, at 90 bar, 40 °C, 50 mg/mL and zein/AMOXI ratio equal to 20/1, spherical microparticles with mean diameter equal to 0.65±0.51 μm were successfully produced. In the case of ampicillin sodium salt, at 90 bar, 50 °C, 50 mg/mL and zein/AMPI ratio equal to 5/1, spherical microparticles with mean diameter equal to 9.0±5.7 μm were precipitated. Drug release analyses revealed that the release of the antibiotics was significantly delayed, confirming that zein/antibiotic coprecipitates obtained by SAS can be used for controlled-release formulations.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11386/4722517
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 16
social impact